Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Public Health Rep. 2011 Mar-Apr;126(2):176-85. doi: 10.1177/003335491112600208.
In September 2008, the Council of State and Territorial Epidemiologists and the Centers for Disease Control and Prevention sponsored a meeting of public health and infection-control professionals to address the implementation of surveillance for multidrug-resistant organisms (MDROs)-particularly those related to health care-associated infections. The group discussed the role of health departments and defined goals for future surveillance activities. Participants identified the following main points: (1) surveillance should guide prevention and infection-control activities, (2) an MDRO surveillance system should be adaptable and not organism specific, (3) new systems should utilize and link existing systems, and (4) automated electronic laboratory reporting will be an important component of surveillance but will take time to develop. Current MDRO reporting mandates and surveillance methods vary across states and localities. Health departments that have not already done so should be proactive in determining what type of system, if any, will fit their needs.
2008 年 9 月,州和地区流行病学家理事会与疾病预防控制中心共同主办了一次公共卫生和感染控制专业人员会议,旨在讨论针对多药耐药生物体(MDRO)的监测的实施情况,特别是那些与医疗保健相关的感染。该小组讨论了卫生部门的作用,并为未来的监测活动定义了目标。与会者确定了以下要点:(1)监测应指导预防和感染控制活动;(2)MDRO 监测系统应具有适应性,而不是针对特定生物体;(3)新系统应利用和链接现有系统;(4)自动化电子实验室报告将是监测的一个重要组成部分,但需要时间来开发。目前,MDRO 的报告要求和监测方法在各州和地方各不相同。尚未这样做的卫生部门应积极主动地确定哪种类型的系统(如果有)适合其需求。